Cat. No.: | PRODRP00108 |
Size: | |
Quantity: |
|
Pricey: | Inquiry |
Source: | Escherichia coli |
Molecular Weight: | Approximately 9.6 kDa, a single non-glycosylated polypeptide chain containing 82 amino acids. |
AA Sequence: | VPIDIDKTKV QNIHPVESAK IEPPDTGLYY DEYLKQVIDV LETDKHFREK LQKADIEEIK SGRLSKELDL VSHHVRTKLD EL |
Purity: | > 95% by SDS-PAGE and HPLC analyses. |
Biological Activity: | Fully biologically active when compared to standard. The biological activity is tested by in vivo assay using healthy wild type male mice (C57BL/6J). |
Physical Appearance: | Sterile filtered white lyophilized (freeze-dried) powder. |
Formulation: | Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH7.4. |
Endotoxin: | Less than 1 EU/µg of rHuNesfatin-1 as determined by LAL method. |
Reconstitution: | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, -20 to -70°C under sterile conditions after reconstitution. |
Synonyms: | Nucleobindin 2 |
Background: | Nesfatin is a metabolic polypeptide derived from the N-terminal region of the precursor protein Nucleobindin2, which is encoded by the NUCB2 gene. Originally identified as a hypothalamic neuropeptide, Nesfatin is naturally occurring and found not only in the hypothalamus but also in other brain regions, pancreatic isletsβ-cells, gastric endocrine cells, and adipocytes. It plays a crucial role in appetite regulation and body fat metabolism. Elevated levels of nesfatin-1 in the brain suppress appetite, reduce hunger frequency, induce a feeling of fullness, and lead to decreased body fat and weight. Conversely, decreased levels of nesfatin-1 in the brain increase appetite, heighten hunger frequency, promote weight gain, and inhibit the feeling of satiety. |